西班牙成人低磷酸酶症诊断标准的外部验证
本研究在西班牙成人队列中验证国际专家提出的低磷酸酶症诊断标准。两项主要标准敏感度95.7%、特异度100%。缺乏生化或基因数据时敏感度下降但特异度保持。
要点
- 基因阳性成人中97.9%符合诊断标准,基因阴性者仅2.8%符合。
- 两项主要标准敏感度95.7%、特异度100%,诊断效能最佳。
- 缺少基因或底物数据时敏感度降低,仅临床特征鉴别价值有限。
核心结论
- 低磷酸酶症诊断标准敏感度和特异度高,支持其临床实用性。
- 具备生化与基因数据时诊断效能最佳,缺少时敏感度降低但特异度保持。
研究设计与样本
- 通过敏感度、特异度、预测值和ROC曲线下面积(AUC)评估诊断效能。
主要发现
- 基因阳性组97.9%满足诊断标准,其中95.7%满足两项主要标准、44.7%满足一项主要加两项次要标准。
- 基因阴性组仅2.8%满足诊断标准。
- 两项主要标准敏感度95.7%、特异度100%;一项主要加两项次要标准敏感度44.7%、特异度97.2%。
- 最具鉴别力的变量为慢性肌肉骨骼疼痛、早期牙齿脱落和软骨钙化。
- 基于底物升高的标准敏感度97.9%、特异度33.3%。
关键数值与推荐
- 基因阳性组中,无基因检测时51.1%满足标准(AUC 0.741)。
- 无底物数据时44.7%满足标准(AUC 0.71)。
- 仅有临床特征时6.4%满足标准(AUC 0.532)。
临床怎么用
- 在持续低碱性磷酸酶成人中,应优先获取生化底物和基因检测以优化诊断效能。
- 缺少基因或底物数据时,诊断标准敏感度降低但特异度保持,需谨慎解读阴性结果。
- 仅凭临床特征鉴别低磷酸酶症价值有限,不应单独用于诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: We evaluated hypophosphatasia diagnostic criteria in adults with low alkaline phosphatase levels and a positive versus negative ALPL genetic test. Performance was optimal with biochemical and genetic data. Without them, sensitivity decreased, though specificity remained. Clinical features alone showed limited discriminative value. PURPOSE: To facilitate early diagnosis of hypophosphatasia (HPP), an international expert group recently proposed standardized diagnostic criteria. This study evaluated the validity and diagnostic utility of the proposed criteria in adults, including scenarios with limited access to tissue-non-specific alkaline phosphatase (TNSALP) substrates and/or genetic assessment. METHODS: Criteria were applied in adults with persistently low alkaline phosphatase levels (ALP) and a positive genetic test (+ GT) confirming HPP versus those with a negative test (-GT). Diagnostic performance was evaluated by sensitivity, specificity, predictive values and area under the ROC curve (AUC). RESULTS: Eighty-three adults were included (47 + GT, 36 -GT). Among + GT individuals, 97.9% met the diagnostic criteria (95.7%, two major; 44.7%, one major and two minor criteria) versus 2.8% of -GT. The two-major criteria arm showed sensitivity of 95.7% and specificity of 100%. The one-major plus two-minor arm had lower sensitivity (44.7%) but high specificity (97.2%). Most discriminative variables were chronic musculoskeletal pain, early tooth loss, and chondrocalcinosis. The criterion based on elevated substrates showed high sensitivity (97.9%) but low specificity (33.3%). In the + GT group, without genetic testing, 51.1% met the criteria (AUC 0.741); without substrate data, 44.7% (AUC 0.71), and with only clinical features, 6.4% (AUC 0.532). CONCLUSION: HPP criteria show high sensitivity and specificity, supporting their clinical utility. Diagnostic performance is optimal when biochemical and genetic data are available. In settings lacking access to genetic testing or substrates, sensitivity is notably reduced despite preserved specificity, and clinical features alone provide limited discriminative value.
引用
- Tornero C, Navarro-Compán V, Heath KE, et al. External validation of the proposed diagnostic criteria for hypophosphatasia in adults of a Spanish cohort. Osteoporos Int. 2026. PMID: 41697313. doi:10.1007/s00198-026-07881-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。